Liver-directed high dose chemotherapy evolved from a highly invasive open surgical procedure to a minimally invasive procedure known as percutaneous hepatic perfusion (PHP). During PHP, three catheters are placed percutaneously through standard interventional radiology techniques. The liver is temporarily isolated from the body’s circulatory system, during which time a 30 minute infusion of the chemotherapeutic agent melphalan hydrochloride directly to the liver occurs. The blood is collected as it exits the liver for filtration by proprietary filters prior to returning it to the patient.
A number of patients have travelled from Ireland to Southampton to have this proceedure. The american company behind the technology is called Delcath and they have an office in Galway. They have a helpful website for patients here www.againsttheodds.eu
Note,
Ocumelirl does NOT promote any treatment, we only report what we find in our travels for your information. Please at all times take appropriate qualified professional medical advice. However medical science is moving so fast that your Dr may not yet be aware of what is happening in other areas so It might be of benefit to point out whats new when you consult with him/her.